Reich Siegfried Insider Trades

Insider Trading History

Track insider trading activity for Reich Siegfried. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Turning Point Therapeutics
Turning Point Therapeutics TPTX
EVP & Chief Scientific Officer
Holding Value $3.69M 48,833 shares
Last Trade
Feb 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.84M 48,833 shares
$37.68
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
EVP & Chief Scientific Officer
Holding Value $260k 3,448 shares
Last Trade
Feb 09, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$14.4k 397 shares
$36.30
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
EVP & Chief Scientific Officer
Holding Value $8.64M 114,450 shares
Last Trade
Mar 04, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.66M 35,550 shares
$103.09
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
EVP & Chief Scientific Officer
Holding Value $2.97M 39,395 shares
Last Trade
Mar 04, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.66M 35,550 shares
$103.09
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
EVP & Chief Scientific Officer
Holding Value $2.75M 36,390 shares
Last Trade
Mar 04, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.73M 35,550 shares
$105.04
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
EVP & Chief Scientific Officer
Holding Value $1.31M 17,303 shares
Last Trade
Feb 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.42M 17,303 shares
$140.01
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
EVP & Chief Scientific Officer
Holding Value $11.3M 150,000 shares
Last Trade
Mar 02, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.69M 150,000 shares
$51.28
$75.49

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up